CYTR...97...https://www.otcmarkets.com/stock/CYTR/news/CytRx-Comments-on-Orphazymes-Promising-24-Month-Interim-Trial-Results-of-Arimoclomol-for-Niemann-Pick-Disease-Type-C?id=309598